Benchmark Reiterates Speculative Buy on HeartBeam, Maintains $8 Price Target
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst Bill Sutherland has reiterated a Speculative Buy rating on HeartBeam (NASDAQ:BEAT) and maintained an $8 price target for the company's stock.
November 16, 2023 | 5:16 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Benchmark analyst Bill Sutherland reaffirmed a Speculative Buy rating on HeartBeam, with a steady price target of $8, indicating a positive outlook for the stock.
The reiteration of a Speculative Buy rating and the maintenance of an $8 price target by a Benchmark analyst could lead to increased investor confidence in HeartBeam, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100